June 5, 2022

Photo by © ASCO/Nick Agro 2022. Written and edited by Lauren Weinand, M.D.  Two groundbreaking studies presented at the 2022 ASCO Annual Meeting discussed the use of brentuximab vedotin to treat classical Hodgkin lymphoma (CHL) in adults as well as children and adolescents. Here are some of the highlights, including MD Newsline’s Q&A session with...